Tibie osteotomy with reconstruction in China typically costs from $14,200 to $23,500. The total price depends on the deformity complexity and surgical technique used. Patients save around 46% compared to the US, where this procedure costs $35,000 on average. Standard hospital packages in major hubs like Beijing and Shanghai often include a 6-day stay.
Bookimed Expert Insight: Choosing a Joint Commission International (JCI) accredited facility like Fuda Cancer Hospital ensures global safety standards. Patients often benefit from integrated recovery approaches unique to China. These programs combine Western surgical precision with traditional medical therapies. This dual approach can optimize long-term mobility results at a lower price point. It is a smart move for patients seeking comprehensive rehabilitation within their initial surgical budget.
| China | Turkey | Austria | |
| Tibie osteotomy with reconstruction | from $14,200 | from $6,000 | from $20,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Tibie osteotomy with reconstruction upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Tibie osteotomy with reconstruction and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Tibie osteotomy with reconstruction journey.
Day 1 - Arrival
Day 2 - Pre-Operation
Day 3 - Surgery
Day 4-7 - Post-Operation
Week 1-2 - Rehabilitation
Week 3-6 - Rehabilitation
Week 7-12 - Rehabilitation
Week 12 and beyond - Final Result
Please note that each patient"s recovery may vary depending on individual factors.
Dr. Niu Lizhi is the President and chief surgeon at Fuda Cancer Hospital in Guangzhou. He has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures. Dr. Niu specializes in minimally invasive oncology for lung, pancreatic, and liver cancers. He treats patients ranging from early childhood through age 94.